Autopsy report · NCT04900428
Study to Evaluate a Single Intranasal Dose of STI-2099 (COVI-DROPS™) in Outpatient Adults With COVID-19 (UK)
Cause of deathFutility
“Study was terminated at interim analysis due to drops not working on new variants”
Life of this trial
- Registered 2 months before it started.
- Ran for about 10 months before it stopped.
- 179 participants enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Phase 2
- Sponsor
- Sorrento Therapeutics, Inc.
- Sponsor type
- Industry
- Conditions
- Covid19
- Interventions
- COVI-DROPS; Placebo
- Participants
- 179
- Sites
- 1
- Countries
- United Kingdom
Trials that died the same way
- Effect of Enzymes on Dental Biofilm Accumulation in Healthy Individuals
“The study was terminated after interim data analysis” - Moxonidine in Patients Undergoing Vascular Surgery
“Study was stopped after pre-definied interim analysis because of no effects” - Intracoronary Bolus Only Compared With Intravenous Bolus and 12-hours Infusion of Abciximab in Non-ST Elevation Myocardial Infarction.
“The study was terminated early due to a shortage of research and analytical personnel, which prevented the completion of the study as planned” - Magrolimab + Azacitidine Versus Azacitidine + Placebo in Untreated Participants With Myelodysplastic Syndrome (MDS)
“Study discontinued due to futility based on a planned analysis” - Adherence to Antidepressant Treatment in Subjects With Depression
“The study was terminated early based on the planned interim analysis that did not meet criteria for continuation.”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.